MRK vs EW
By Alex · Tickerpine
Merck & Co., Inc. vs Edwards Lifesciences Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | EW |
|---|---|---|
| Price | $148.78 | $86.29 |
| Market cap | $367.07B | $49.74B |
| P/E ratio | 119.0 | 51.4 |
| ROE | 6.96% | 9.18% |
| Profit margin | 4.77% | 15.43% |
| Revenue growth | 5.10% | 13.60% |
| Dividend yield | 2.29% | — |
| Beta | 0.23 | 0.85 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs EW in plain English
- MRK is the bigger company — about 7.4× the market cap of EW.
- EW is cheaper on earnings (P/E 51.4 vs 119.0).
- EW earns a higher return on equity (9% vs 7%).
- EW is growing revenue faster (14% vs 5%).
- MRK pays a dividend (2.29%) while the other effectively doesn't.
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
EW return calculator
See what $1,000 in Edwards Lifesciences Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.